RG
Renata Gołębiowska-Wiatrak

Well Cited


24
Works
262
Citations
6
H-Index
Search Authors
Author Statistics
  • OpenAlex ID A5024093697
  • i10-Index 6
  • 2-Yr Mean Citedness 0.00
External Links

Renata Gołębiowska-Wiatrak

Also known as: Golebiowska-Wiatrak, Renata, Gołębiowska-Wiatrak, Renata, R Golebiowska-Wiatrak, Renata Golebiowska, Renata Golebiowska-Wiatrak

24

Total Works

262

Citations

6

H-Index

6

i10-Index

Citation & Works Trend by Year
15 years active
Top Research Topics
Fatty Acid Research and Health (11) Nutritional Studies and Diet (6) Blood properties and coagulation (6) Paraoxonase enzyme and polymorphisms (5) Heart Failure Treatment and Management (4)
Recent Publications
14 shown
Year Publication Title Citations Action
2024 Blood clot properties, thrombin generation, and platelet activation in patients with dysglycemia and established atherosclerotic cardiovascular disease: The CASCARA study Kardiologia Polska 5
2023 Gender-related and PUFA-related differences in lipoprotein-associated phospholipase A2 levels in patients with type 2 diabetes and atherosclerotic cardiovascular disease Advances in Clinical and Experimental Medicine 2
2023 Gender-related and PUFA-related differences in lipoprotein-associated phospholipase a2 level, in patients with type 2 diabetes and atherosclerotic cardiovascular disease Advances in Clinical and Experimental Medicine 0
2019 Unsaturated fatty acid composition in serum phospholipids in patients in the acute phase of myocardial infarction Kardiologia Polska 6
2018 Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation Cardiovascular Diabetology 20
2018 P2532Association of serum phospholipid cis-palmitoleic acid with diabetes duration, systemic inflammation and circulating oxLDL in type 2 diabetic patients with atherosclerotic cardiovascular disease European Heart Journal 0
2018 Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD) Atherosclerosis 52
2018 Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease Cardiovascular Diabetology 58
2017 Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes Cardiovascular Diabetology 98
2017 MOESM1 of Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes Figshare 0
2015 CHA2DS2-VASc: towards a universal risk assessment in cardiovascular diseases? Polskie Archiwum Medycyny Wewnętrznej 1
2015 Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet’ Response to Clopidogrel in Patients with Stable Angina Advances in Clinical and Experimental Medicine 10
2013 Serum biomarkers and clinical outcomes in heart failure patients treated de novo with carvedilol Cardiology Journal 10
2010 Statins and Response to Carvedilol Given to Patients with Chronic Heart Failure Journal of Cardiac Failure 0

Data source: OpenAlex API